Fig. 1
Overall Survival in months for patients treated with IL-2 alone or IL-2 following PD-1 inhibition in metastatic melanoma (a) and metastatic renal cell carcinoma (b)
Fig. 1 | Journal for ImmunoTherapy of Cancer
Overall Survival in months for patients treated with IL-2 alone or IL-2 following PD-1 inhibition in metastatic melanoma (a) and metastatic renal cell carcinoma (b)